logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

Dennis Dong Hwan Kim

University of Toronto

35H-index
417Paper Count
1.2WCitation Count
Published Papers 81
Publication Date
logo
ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors
errLeukemia
IF13.4
err2026-04-23
err0
errOAAI
errAndreas Hochhaus; Philipp le Coutre; Dragana Milojkovic; Dennis Dong Hwan Kim; Soo Min Lim; Carolina Pavlovsky; Thanh Nguyen; Franck Emmanuel Nicolini; Beatriz Moiraghi; Sebastian Grosicki; Chi Dung Phu; Gabriel Etienne; Fernando Marco de Lucas; Rosa Maria Ayala Diaz; Massimo Breccia; Charles Chuah; Roberto Abi Rached; Himanshu Pokhriyal; Aswin IC; Peter Schuld; Virginia Pilipovic; Franz Alisch; Carla Maria Boquimpani
errShare
errSave
Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation
errBone Marrow Transplantation
IF5.2
err2026-04-03
err0
errOAAI
errKristina Maas-Bauer; Thomas Meyer; Mehtap Yücel; Maria Garofalaki; Stefanie Koßmann; Francesca Biavasco; Memnon Lysandrou; Miguel Waterhouse; Tobias Feuchtinger; Dietmar Pfeifer; Florian Ingelfinger; Tobias Wertheimer; Justus Duyster; Jae Sook Ahn; Robert J. Soiffer; Jürgen Finke; Ralph Wäsch; Alexandros Spyridonidis; Dennis Dong Hwan Kim; Claudia Wehr; Robert Zeiser
errShare
errSave
The adverse prognostic impact of HMGCLL1 gene variants can be abrogated by frontline second-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
errLeukemia
IF13.4
err2026-03-30
err0
PREAI
errMaria Agustina Perusini; Katia Pagnano; Carolina Pavlovsky; Daniela Žáčková; Jiří Mayer; Beatriz Moiraghi; Ana Ines Varela; Michele Bianchini; Ana Beatriz Pascoal Lopes; Gislaine Duarte; Carmino Antonio de Souza; Ivana Ježíšková; Anežka Kvetková; Tomáš Jurček; Hye Won Lee; Myung Hee Chang; Jessie J. F. Medeiros; Sagi Abelson; Dennis Dong Hwan Kim
errShare
errSave
Underreported and underreviewed: Addressing the gaps in TKI tolerability literature for chronic myeloid leukemia
errBlood Reviews
IF5.7
err2026-02-26
err0
PREAI
errDennis Dong Hwan Kim; Daniela Zackova; Massimo Breccia; Fabian Lang; Emiko Sakaida; Qian Jiang; Raquel De Paz; Bingcheng Liu; Susanne Isfort; David Yeung; Tomoiku Takaku; Tim H. Brümmendorf
errShare
errSave
Frailty as a prognostic factor in younger adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
errTransplantation and Cellular Therapy
IF4.4
err2026-01-20
err0
PREAI
errSergio Rodriguez-Rodriguez; Maria Queralt Salas; Nihar Desai; Eshrak Al-Shaibani; Igor Novitzky-Basso; Ivan Pasic; Auro Viswabandya; Fotios V. Michelis; Jonas Mattsson; Dennis Dong Hwan Kim; Rajat Kumar; Tommy Alfaro Moya
errShare
errSave
A small step yet one giant leap for cGVHD biomarkers
errBlood
IF23.1
err2026-01-15
err0
PREAI
errIgor Novitzky-Basso; Dennis Dong Hwan Kim
errShare
errSave
Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in ASC4FIRST
errBlood
IF23.1
err2025-12-17
err0
errOAAI
errJorge E. Cortes; Timothy P. Hughes; Jianxiang Wang; Dong-Wook Kim; Dennis Dong Hwan Kim; Jiri Mayer; Yeow-Tee Goh; Philipp le Coutre; Gabriel Etienne; Inho Kim; David J. Andorsky; Felice Bombaci; Ghayas C. Issa; Naoto Takahashi; Shruti Kapoor; Rajendra Jinwal; Kamel Malek; Tracey McCulloch; Lillian Yau; Richard A. Larson
errShare
errSave
Olverembatinib in chronic myeloid leukemia: is less actually better?
errHAEMATOLOGICA
IF7.9
err2025-12-01
err0
errOAAI
errPerusini, Maria Agustina; Kim, Dennis Dong Hwan
errShare
errSave
Eltrombopag in Treating Post-Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug Tapering
errEUROPEAN JOURNAL OF HAEMATOLOGY
IF2.3
err2025-12-01
err1
PREAI
errAl-Omari, Rawan; Nampoothiri, Ram Vasudevan; Sakhdari, Ali; Atenafu, Eshetu G.; Chiarello, Caden; Kim, Dennis D.; Law, Arjun; Pasic, Ivan; Novitzky-Basso, Igor; Viswabandya, Auro; Michelis, Fotios V.; Mattsson, Jonas; Kumar, Rajat
errShare
errSave
Herpes zoster frequency and adjuvanted recombinant zoster vaccination after allogeneic hematopoietic cell transplantation
errTransplantation and Cellular Therapy
IF4.4
err2025-10-28
err0
PREAI
errVictoria G Hall; Caden Chiarello; Mats Remberger; Deepali Kumar; Ivan Pasic; Dennis Dong Hwan Kim; Rajat Kumar; Auro Viswabandya; Fotios V Michelis; Arjun Law; Armin Gerbitz; Sapna Humar; Wilson Lam; Igor Novitzky-Basso; Jonas Mattsson
errShare
errSave
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival
errAnnals of Hematology
IF2.4
err2025-10-25
err0
errOAAI
errSergio Rodriguez-Rodriguez; Nihar Desai; Christopher Lemieux; Keven Vachon; Kareem Jamani; Mohamed Elemary; Tommy Alfaro-Moya; Eshrak Al-Shaibani; Ivan Pasic; Igor Novitzky-Basso; Fotios Michelis; Auro Viswabandya; Rajat Kumar; Jonas Mattsson; Arjun Law; Sylvie Lachance; Dennis Dong Hwan Kim
errShare
errSave
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis
errBritish Journal of Haematology
IF3.8
err2025-09-18
err0
PREAI
errRuah Alyamany; Ahmed Alnughmush; Mats Remberger; Arjun Datt Law; Wilson Lam; Dennis (Dong Hwan) Kim; Fotios V. Michelis; Ivan Pasic; Igor Novitzky-Basso; Armin Gerbitz; Rajat Kumar; Jonas Mattsson; Auro Viswabandya
errShare
errSave
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment
errBritish Journal of Haematology
IF3.8
err2025-09-14
err0
errOAAI
errSergio Rodriguez-Rodriguez; Nihar Desai; Carol Chen; Kareem Jamani; Catherine Sohier-Poirier; Christopher Lemieux; Jennifer White; Mohamed Elemary; Michael Kennah; Tommy Alfaro Moya; Eshrak Al-Shaibani; Igor Novitzky-Basso; Ivan Pasic; Arjun Datt Law; Fotios V. Michelis; Auro Viswabandya; Rajat Kumar; Jonas Mattsson; Dennis Dong Hwan Kim
errShare
errSave
A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation
errBritish Journal of Haematology
IF3.8
err2025-08-27
err0
PREAI
errNihar Desai; Sergio Rodriguez-Rodriguez; Eshrak Al-Shaibani; Tommy Alfaro Moya; Arjun Datt Law; Igor Novitzky-Basso; Ivan Pasic; Fotios V. Michelis; Rajat Kumar; Dennis Dong Hwan Kim; Jonas Mattsson; Auro Viswabandya
errShare
errSave
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation
errBritish Journal of Haematology
IF3.8
err2025-07-19
err0
PREAI
errNihar Desai; Eshrak Al-Shaibani; Tommy Alfaro-Moya; Arjun D. Law; Wilson Lam; Mats Remberger; Ivan Pasic; Igor Novitzky-Basso; Auro Viswabandya; Dennis D. Kim; Rajat Kumar; Jeffrey H. Lipton; Jonas Mattsson; Fotios V. Michelis
errShare
errSave
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant With Graft Failure and Relapse Risk in Hematological Malignancies
errTransplantation and Cellular Therapy
IF4.4
err2025-06-11
err0
PREAI
errAhmed Alnughmush; Mats Remberger; Vathany Kulasingam; Ivan Pasic; Igor Novitzky-Basso; Arjun D. Law; Wilson Lam; Dennis D. Kim; Armin Gerbitz; Rajat Kumar; Auro Viswabandya; Jonas Mattsson; Fotios V. Michelis
errShare
errSave
Conditioning Regimens for Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Graft Failure
errTransplantation and Cellular Therapy
IF4.4
err2025-06-11
err0
PREAI
errNihar Desai; Sergio Rodriguez Rodriguez; Carol Chen; Eshetu G. Atenafu; Tommy Alfaro-Moya; Arjun Datt Law; Eshrak Al-Shaibani; Igor Novitzky-Basso; Ivan Pasic; Fotios V. Michelis; Auro Viswabandya; Dennis D. Kim; Jonas Mattsson; Rajat Kumar
errShare
errSave
Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL
errBlood Advances
IF7.1
err2025-05-09
err0
errOAAI
errMichael J. Mauro; Yosuke Minami; Andreas Hochhaus; Elza Lomaia; Sergey Voloshin; Anna Turkina; Dong-Wook Kim; Jane F. Apperley; Jorge E. Cortes; Andre Abdo; Laura Maria Fogliatto; Dennis Dong Hwan Kim; Philipp le Coutre; Susanne Saussele; Mario Annunziata; Timothy P. Hughes; Naeem Chaudhri; Lynette Chee; Valentin García-Gutiérrez; Koji Sasaki; Carla Boquimpani; Shruti Kapoor; Noemi Espurz; Vishal Dhamal; Delphine Rea
errShare
errSave
Systematic Review and Meta-Analysis of Extracorporeal Photopheresis for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease
errTRANSPLANTATION AND CELLULAR THERAPY
IF4.4
err2025-02-01
err0
errOAAI
errDefilipp, Zachariah; Fox, Laura; Holderried, Tobias A. W.; Mehra, Varun; Michonneau, David; Pashley, Alex; Karlsson, Andrei; Kim, Dennis Dong Hwan
errShare
errSave
Asciminib versus bosutinib following 2 or more prior therapies in chronic myeloid leukemia: a plain language summary of the ASCEMBL study
errFUTURE ONCOLOGY
IF2.6
err2025-01-09
err0
errOAAI
errSzuber, Natasha; Machado, Lisa; Kim, Dennis Dong Hwan
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
Jörge E. Cortes
H-index: 179 · Papers: 3.6K
B
Bruce R. Blazar
H-index: 148 · Papers: 1.5K
R
Richard A. Larson
H-index: 147 · Papers: 1.5K
R
Richard N. Bergman
H-index: 143 · Papers: 923
M
Michael A. Caligiuri
H-index: 135 · Papers: 864
View more